Yahoo
Toronto - Delayed Quote CAD

Knight Therapeutics Inc. (GUD.TO)

11.27 -0.13 (-1.14%)
At close: October 30 at 4:00:01 PM EDT
View in AlphaSpace Currency in CAD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
547,305
450,088
371,304
328,199
293,563
Cost of Revenue
288,048
249,858
196,899
175,547
155,502
Gross Profit
259,257
200,230
174,405
152,652
138,061
Operating Expense
232,863
202,580
167,008
146,282
155,121
Operating Income
26,394
-2,350
7,397
6,370
-17,060
Net Non Operating Interest Income Expense
-6,879
-4,216
1,187
87
4,032
Other Income Expense
1,871
-136
-6,532
-28,445
-30,932
Pretax Income
21,386
-6,702
2,052
-21,988
-43,960
Tax Provision
6,515
-1,328
-2,280
-5,153
-14,068
Net Income Common Stockholders
14,871
-5,374
4,332
-16,835
-29,892
Diluted NI Available to Com Stockholders
14,871
-5,374
4,332
-16,835
-29,892
Basic EPS
0.15
-0.05
0.04
-0.16
-0.26
Diluted EPS
0.15
-0.05
0.04
-0.16
-0.26
Basic Average Shares
98,912.41
99,566.53
101,040.58
107,465.98
114,890.25
Diluted Average Shares
99,331.05
99,566.53
101,436.90
107,465.98
114,890.25
Total Operating Income as Reported
26,394
-2,350
7,397
-2,890
-41,044
Total Expenses
520,911
452,438
363,907
321,829
310,623
Net Income from Continuing & Discontinued Operation
14,871
-5,374
4,332
-16,835
-29,892
Normalized Income
16,174.11
-7,087.07
9,071.50
7,179.10
-6,121.24
Interest Income
4,179
6,206
10,410
12,575
10,632
Interest Expense
11,058
10,422
9,223
12,488
6,600
Net Interest Income
-6,879
-4,216
1,187
87
4,032
EBIT
32,444
3,720
11,275
-9,500
-37,360
EBITDA
96,490
60,289
64,384
40,897
25,261
Reconciled Cost of Revenue
281,416
242,776
188,145
170,190
144,623
Reconciled Depreciation
64,046
56,569
53,109
50,397
62,621
Net Income from Continuing Operation Net Minority Interest
14,871
-5,374
4,332
-16,835
-29,892
Total Unusual Items Excluding Goodwill
-1,874
2,136
-6,403
-31,350
-34,957
Total Unusual Items
-1,874
2,136
-6,403
-31,350
-34,957
Normalized EBITDA
98,364
58,153
70,787
72,247
60,218
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-570.89
422.93
-1,663.50
-7,335.90
-11,186.24
12/31/2022 - 3/3/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: